Shoulder Injection with Depo-Medrol
For shoulder injections, use 20-80 mg of Depo-Medrol (methylprednisolone acetate) depending on the specific structure targeted: 20-80 mg for glenohumeral joint, 20-80 mg for subacromial bursa, and 4-10 mg for acromioclavicular joint. 1
Dosing by Joint Structure
The FDA-approved dosing for shoulder injections varies by anatomical target 1:
- Large joints (glenohumeral, subacromial space): 20-80 mg
- Medium joints (not applicable to shoulder): 10-40 mg
- Small joints (acromioclavicular, sternoclavicular): 4-10 mg
Most practitioners use 40-80 mg for subacromial and glenohumeral injections, with 80 mg showing faster pain relief in comparative studies 2. A 2009 survey found that >98% of specialists stay within recommended doses for subacromial and glenohumeral injections, though 41% of surgeons exceed recommendations for AC joint injections 3.
Injection Technique
Preparation and Approach
Use strict aseptic technique as you would for lumbar puncture 1. The posterior approach is most commonly used for glenohumeral injections 4, while subacromial injections can be performed via lateral or posterior approaches 5.
Critical Technical Points
- Use a 20-24 gauge needle on a dry syringe 1
- Aspirate a few drops of synovial fluid to confirm intra-articular placement 1
- Never inject directly into tendons—target the synovial space, bursa, or tendon sheath 6
- Avoid the deltoid muscle due to high risk of subcutaneous atrophy 1
- After injection, gently move the joint a few times to distribute the medication 1
Important Caveat on Dilution
Do not dilute or mix Depo-Medrol with other solutions due to physical incompatibilities 1. While some practitioners add local anesthetic, the FDA label explicitly warns against mixing. If local anesthetic is desired for diagnostic purposes, it should be in a separate syringe.
Post-Injection Management
Avoid overuse of the injected joint for 24 hours, but do not immobilize 7. This EULAR recommendation (Grade A, Level 1B evidence) balances rest with prevention of stiffness.
Patient Counseling Points
- Diabetic patients must monitor glucose levels closely on days 1-3 post-injection due to transient hyperglycemia 7
- Expect potential improvement within 10-30 minutes, with sustained relief over 2 weeks 2
- Approximately 53% of patients with adhesive capsulitis achieve clinically meaningful pain relief (>1.5 points VAS reduction) and ROM improvement (≥20°) at 12 weeks 4
Re-injection Timing
Wait at least 1-5 weeks between injections depending on response 1. The decision to re-inject should consider benefits from previous injections and individual factors 7. Repeated injections are not advised as standard practice 6, and injections should be performed at least 3 months prior to planned joint replacement surgery 7.
Safety Considerations
Contraindications and Precautions
- Rule out infection before injecting—do not administer intra-articular steroids without appropriate diagnosis 7
- Patients on anticoagulation can receive injections unless bleeding risk is high 7
- This product is single-dose only; discard any remaining suspension 1
- Rare anaphylactoid reactions have occurred 1
Adverse Effects to Monitor
- Dermal/subdermal atrophy at injection site (minimize by using proper technique and avoiding excessive doses) 1
- HPA axis suppression with chronic use 1
- Increased infection susceptibility 1
- Transient hyperglycemia, particularly in diabetics 7
Formulation Warning
Never use Depo-Medrol intrathecally—the polyethylene glycol and myristyl-gamma-picolinium chloride excipients are neurotoxic via this route 8. This is relevant only if considering epidural injections near the shoulder region.
Evidence Quality Note
Methylprednisolone acetate (Depo-Medrol) shows faster pain relief compared to triamcinolone acetonide in ultrasound-guided shoulder injections, with 92% vs 50% achieving ≥50% pain relief at 2 weeks 2. However, this was a small study (n=24), and both agents showed similar overall efficacy. The choice between corticosteroids remains largely based on clinician preference, with Depo-Medrol and Kenalog being most commonly used across specialties 3.